DNAnexus
PrivateLast Round
Series I
Mar 8, 2022
Est. Valuation
$600M
Total Funding Raised
$472.55M
Company Overview
DNAnexus is a healthcare software company that provides a secure, cloud-based platform for biomedical informatics and data management to accelerate precision health and scientific discovery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Cloud Infrastructure, Data Integration, Drug Discovery
Business Model
B2B
Customer Profile
Usage-Based SaaS, Subscription SaaS, Services & Consulting, Government Contracts
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DNAnexus Comparables
Compare DNAnexus with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Velsera | 85% | |
| Lifebit | 79% | |
| Danaher Corporation | 78% | |
DNAnexus Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series I | Mar 8, 2022 | ||||
| Series G | Jun 9, 2020 | ||||
| Series F | Feb 6, 2019 | ||||
| Series E | Jan 2, 2018 | ||||
| Series D | Apr 22, 2015 | ||||
Series C | Jan 3, 2014 |
Key People
Founding team and executive leadership
DNAnexus Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Uncork Capital | Seed, Series B |
| Innovatus Capital Partners | Series I, Series F |
| GV | Series E, Series I, Series G, Series C, Series F, Series B |
| Perceptive Advisors | Series I, Series G |
| M12 - Microsoft's Venture Fund | Series E |
| Northpond Ventures | Series I, Series G |
| Foresite Capital | Series I, Series G, Series E, Series F |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 28, 2025
Dr. Oakland departs as VP and Product Lead for precision oncology.
- Aug 28, 2025
Dr. Oakland joins as VP and Product Lead.
DNAnexus Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about DNAnexus's valuation, stock price, and market status.